For NMR spectra the substrates were dissolved in CDCl 3 and the spectra recorded on a Bruker AVANCE 300 III, 250 II or 500. The IR spectra were measured as ATR experiments with a Nicolet 6700 FT-IR spectrometer and a Nicolet 550 FT-IR spectrometer. MS and Estrone (8.0 mmol, 2.163 g), 4-dimethylaminopyridine (DMAP, 1.6 mmol, 0.195 g) and 2,6-lutidine (17.2 mmol, 1.843 g) were dissolved in dichloromethane (80 mL) and cooled to 0 °C. Tf 2 O (21.3 mmol, 6.004 g) was added dropwise and the reaction was stirred for 2 h at 0 °C, then further 4 h at room temperature. 1M HCl (80 mL) was added and the reaction was stirred rigorously for 15 min. The organic phase was separated, washed with brine (80 mL), dried and filtered. The filtrate was concentrated in vacuo and the crude product was purified by column chromatography (heptane/ethyl acetate 15:1) to yield 1 as a colourless oil (3.378 g, 79 %). 
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